Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-25 Sale |
2024-11-27 4:11 pm |
ARS Pharmaceuticals Inc. | SPRY | Chakma Justin Chief Business Officer |
100,000 | $14.12 | $1,411,742 | 136,380 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $13.95 | $1,394,960 | 10,218,153 (Indirect Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) |
View |
| 2024-11-12 Sale |
2024-11-14 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $16.85 | $1,684,642 | 10,369,106 (Indirect Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 8:16 pm |
ARS Pharmaceuticals Inc. | SPRY | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner |
563,270 | $18.01 | $10,143,706 | 5,257,328 (Indirect) |
View |
| 2024-10-16 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $16 | $200,000 | 815,529 (Indirect Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) |
View |
| 2024-10-15 Sale |
2024-10-17 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $14.88 | $1,487,595 | 10,368,153 (Indirect Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 4:28 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) |
View |
| 2024-10-08 Sale |
2024-10-10 4:27 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $13.83 | $1,382,775 | 10,519,106 (Indirect Direct) |
View |
| 2024-09-18 Sale |
2024-09-19 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 600,281 (Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:29 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) |
View |
| 2024-09-17 Sale |
2024-09-19 4:26 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $12.93 | $1,293,205 | 10,518,153 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 4:25 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $11.5 | $1,149,775 | 10,669,106 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 4:24 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $11.5 | $1,149,775 | 10,669,106 (Indirect Direct) |
View |
| 2024-08-26 Sale |
2024-08-28 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) |
View |
| 2024-08-26 Sale |
2024-08-28 4:26 pm |
ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
83,695 | $13 | $1,088,035 | 8,288,510 (Indirect) |
View |
| 2024-08-21 Sale |
2024-08-23 6:41 pm |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) |
View |
| 2024-08-21 Sale |
2024-08-23 6:38 pm |
ARS Pharmaceuticals Inc. | SPRY | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
868,682 | $13.24 | $11,497,963 | 8,372,205 (Indirect) |
View |
| 2024-08-20 Sale |
2024-08-21 6:51 pm |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
50,000 | $15 | $750,000 | 67,852 (Direct) |
View |
| 2024-08-19 Sale |
2024-08-21 6:51 pm |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $14 | $140,000 | 610,281 (Direct) |
View |
| 2024-08-20 Sale |
2024-08-21 6:49 pm |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $16 | $200,000 | 828,029 (Direct) |
View |
| 2024-08-20 Sale |
2024-08-21 6:48 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $15.03 | $1,502,587 | 10,668,153 (Indirect Direct) |
View |
| 2024-08-20 Sale |
2024-08-21 6:47 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $15.03 | $1,502,587 | 10,668,153 (Indirect Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
30,000 | $13 | $390,000 | 117,852 (Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $12.48 | $1,247,555 | 10,819,106 (Indirect Direct) |
View |
| 2024-08-13 Sale |
2024-08-15 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $12.48 | $1,247,555 | 10,819,106 (Indirect Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $11.4 | $1,140,295 | 10,818,153 (Indirect Direct) |
View |
| 2024-07-16 Sale |
2024-07-18 4:30 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $11.4 | $1,140,295 | 10,818,153 (Indirect Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 5:04 pm |
ARS Pharmaceuticals Inc. | SPRY | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
100,000 | $9.6173 | $961,725 | 10,969,106 (Indirect Direct) |
View |
| 2024-07-09 Sale |
2024-07-11 5:03 pm |
ARS Pharmaceuticals Inc. | SPRY | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
100,000 | $9.6173 | $961,725 | 10,969,106 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-16 Exercise |
2024-10-17 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $1.5 | 815,529 (Direct) |
View |
| 2024-10-16 Exercise |
2024-10-17 4:30 pm |
N/A 2032-02-29 |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $0 | 815,529 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 600,281 (Direct) |
View |
| 2024-09-18 Exercise |
2024-09-19 4:30 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 600,281 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:51 pm |
N/A 2028-11-28 |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
50,000 | $0 | 67,852 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:51 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
50,000 | $0.64 | 67,852 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 6:51 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $1.5 | 610,281 (Direct) |
View |
| 2024-08-19 Exercise |
2024-08-21 6:51 pm |
N/A 2032-05-23 |
ARS Pharmaceuticals Inc. | SPRY | Karas Eric Chief Commercial Officer |
10,000 | $0 | 610,281 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:49 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $1.5 | 828,029 (Direct) |
View |
| 2024-08-20 Exercise |
2024-08-21 6:49 pm |
N/A 2032-02-29 |
ARS Pharmaceuticals Inc. | SPRY | Scott Kathleen D. Chief Financial Officer |
12,500 | $0 | 828,029 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 4:30 pm |
N/A 2028-11-28 |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
30,000 | $0 | 117,852 (Direct) |
View |
| 2024-08-13 Exercise |
2024-08-15 4:30 pm |
N/A N/A |
ARS Pharmaceuticals Inc. | SPRY | Dorsey Brian Chief Operating Officer |
30,000 | $0.64 | 117,852 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:13 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
40,000 | $0 | 40,000 (Indirect) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:06 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Dadoo Rajeev Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Shawver Laura Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Shah Pratik Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | SCHNEIDER PHILLIP M Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Islam Saqib Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Kelly Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2024-06-20 Option Award |
2024-06-24 5:00 pm |
N/A 2034-06-19 |
ARS Pharmaceuticals Inc. | SPRY | Thompson Peter A. Director |
40,000 | $0 | 40,000 (Direct) |
View |